Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News Stock Photo

RMID:2DM090B

Image details

Contributor:

Ian Rutherford / Alamy Stock Photo

Image ID:

2DM090B

File size:

58.6 MB (3 MB Compressed download)

Releases:

Model - no | Property - noDo I need a release?

Dimensions:

5616 x 3649 px | 47.5 x 30.9 cm | 18.7 x 12.2 inches | 300dpi

Date taken:

16 December 2020

Location:

Livingston, Scotland

More information:

This image could have imperfections as it’s either historical or reportage.

Available for editorial and personal use only. Get in touch for commercial uses.

Search stock photos by tags

Similar stock images

RM2DM08TX–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

RM2DM08WB–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

RM2DM0902–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

RM2DM08X2–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

RM2DM08TB–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

RM2DM08YG–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News

RM2DM090R–Livingston, West Lothian, UK. 16th Dec, 2020. General view of the Valneva facility, Oakbank Industrial Estate. Clinical trials have started in the UK for a coronavirus vaccine being manufactured in West Lothian. The Valneva candidate vaccine will initially be tested on 150 volunteers at testing sites in Birmingham, Bristol, Newcastle and Southampton. It is being developed in Livingston and the UK government has pre-ordered 60 million doses. Oakbank, Livingston, Scotland, UK. 16th December 2020. Credit: Ian Rutherford/Alamy Live News